Quantitative Multiplex Immunohistochemistry Identifies Immunosuppression in the AML Bone Marrow and NK-Cells As Prognostic Biomarker in Intermediate-Risk Patients

JSON

Brück O, Dufva O, Blom S, Turkki R, Ilander M, Siitonen SM, Kovanen P, Pallaud C, Marques Ramos P, Lähteenmäki H, Välimäki K, Ribeiro A, Kallioniemi O, Porkka K, Pellinen T, Mustjoki S

Blood 132 (Supplement 1) 2774-2774 [2018-11-29; online 2018-11-29]

DOI 10.1182/blood-2018-99-116628

Crossref 10.1182/blood-2018-99-116628